Mosaiques utilizes proteomic analysis to scan the body at a molecular level.

This approach provides significant benefits for managing chronic diseases, including cancer.

Mosaiques' proteome analysis:

• Detects diseases before organ damage occurs.
• Leverages this breakthrough for early detection and targeted therapy (personalized medicine).

Mosaiques marks the end of the "divining rod race":

• Provides proteome-based biomarkers of diseases at the molecular level.
• Utilizes the highest quality clinical database for precision and reliability.